UK markets open in 4 hours 26 minutes
  • NIKKEI 225

    28,009.84
    -397.00 (-1.40%)
     
  • HANG SENG

    28,593.81
    +399.72 (+1.42%)
     
  • CRUDE OIL

    64.75
    -0.74 (-1.13%)
     
  • GOLD FUTURES

    1,867.10
    -0.90 (-0.05%)
     
  • DOW

    34,060.66
    -267.13 (-0.78%)
     
  • BTC-GBP

    28,852.29
    -2,925.59 (-9.21%)
     
  • CMC Crypto 200

    1,140.05
    -113.10 (-9.03%)
     
  • ^IXIC

    13,303.64
    -75.41 (-0.56%)
     
  • ^FTAS

    4,007.57
    +4.67 (+0.12%)
     

Global Vitamin D Therapy Market to Reach $4.2 Billion by 2027

ReportLinker
·26-min read

Abstract: - Global Vitamin D Therapy Market to Reach $4. 2 Billion by 2027. - Amid the COVID-19 crisis, the global market for Vitamin D Therapy estimated at US$2. 1 Billion in the year 2020, is projected to reach a revised size of US$4.

New York, April 13, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Vitamin D Therapy Industry" - https://www.reportlinker.com/p06033260/?utm_source=GNW
2 Billion by 2027, growing at aCAGR of 10.8% over the period 2020-2027. Oral, one of the segments analyzed in the report, is projected to record 11.1% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Parenteral segment is readjusted to a revised 10.1% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $610.2 Million, While China is Forecast to Grow at 10.4% CAGR
- The Vitamin D Therapy market in the U.S. is estimated at US$610.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$743.7 Million by the year 2027 trailing a CAGR of 10.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.5% and 9.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

- Select Competitors (Total 36 Featured) -

  • Abbott

  • Alkem Laboratories Ltd.

  • Cadila Healthcare Ltd.

  • GlaxoSmithKline PLC

  • Merck & Co., Inc.

  • Novartis AG

  • Pfizer Inc

  • Sanofi

  • Sun Pharmaceutical Industries Ltd.

  • Torrent Pharmaceuticals Ltd.




Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Vitamin D Therapy
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Vitamin D Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Oral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Oral by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Oral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Parenteral by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Parenteral by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Parenteral by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Osteoporosis by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Osteoporosis by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Osteoporosis by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Rickets by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Rickets by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Rickets by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Muscle Weakness
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Muscle Weakness by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Muscle Weakness by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Autoimmune
Disorders by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 23: World Historic Review for Autoimmune Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Autoimmune Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Skin Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Skin Diseases by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Skin Diseases by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Prescription
Drugs by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Prescription Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Prescription Drugs by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for OTC Drugs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for OTC Drugs by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for OTC Drugs by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 34: USA Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: USA Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 36: USA 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 40: USA Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 41: USA Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 42: USA 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: Canada 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 49: Canada Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 51: Canada 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 53: Japan Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Japan 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 58: Japan Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 59: Japan Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 60: Japan 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

CHINA
Table 61: China Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: China Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: China 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 67: China Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 68: China Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: China 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

EUROPE
Table 70: Europe Current & Future Analysis for Vitamin D
Therapy by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Vitamin D Therapy by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Vitamin D Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: Europe 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 79: Europe Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: Europe 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 84: France 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 88: France Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 90: France 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Vitamin D Therapy by
Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 93: Germany 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 97: Germany Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 99: Germany 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

ITALY
Table 100: Italy Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Vitamin D Therapy by Route
Of Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: Italy 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 106: Italy Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Italy Historic Review for Vitamin D Therapy by
Method - Prescription Drugs and OTC Drugs Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 108: Italy 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 109: UK Current & Future Analysis for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 110: UK Historic Review for Vitamin D Therapy by Route Of
Administration - Oral and Parenteral Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 111: UK 15-Year Perspective for Vitamin D Therapy by
Route Of Administration - Percentage Breakdown of Value Sales
for Oral and Parenteral for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: UK Historic Review for Vitamin D Therapy by
Application - Other Applications, Osteoporosis, Rickets, Muscle
Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Vitamin D Therapy by
Application - Percentage Breakdown of Value Sales for Other
Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 115: UK Current & Future Analysis for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 116: UK Historic Review for Vitamin D Therapy by Method -
Prescription Drugs and OTC Drugs Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 117: UK 15-Year Perspective for Vitamin D Therapy by
Method - Percentage Breakdown of Value Sales for Prescription
Drugs and OTC Drugs for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 118: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: Rest of Europe Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 120: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2012, 2020 &
2027

Table 121: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 122: Rest of Europe Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 123: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Application - Percentage Breakdown of Value Sales
for Other Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 124: Rest of Europe Current & Future Analysis for Vitamin
D Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 125: Rest of Europe Historic Review for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 126: Rest of Europe 15-Year Perspective for Vitamin D
Therapy by Method - Percentage Breakdown of Value Sales for
Prescription Drugs and OTC Drugs for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 127: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 128: Asia-Pacific Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 129: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2012, 2020 &
2027

Table 130: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Application - Other Applications, Osteoporosis,
Rickets, Muscle Weakness, Autoimmune Disorders and Skin
Diseases - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Asia-Pacific Historic Review for Vitamin D Therapy
by Application - Other Applications, Osteoporosis, Rickets,
Muscle Weakness, Autoimmune Disorders and Skin Diseases Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 132: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Application - Percentage Breakdown of Value Sales
for Other Applications, Osteoporosis, Rickets, Muscle Weakness,
Autoimmune Disorders and Skin Diseases for the Years 2012, 2020 &
2027

Table 133: Asia-Pacific Current & Future Analysis for Vitamin D
Therapy by Method - Prescription Drugs and OTC Drugs -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 134: Asia-Pacific Historic Review for Vitamin D Therapy
by Method - Prescription Drugs and OTC Drugs Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 135: Asia-Pacific 15-Year Perspective for Vitamin D
Therapy by Method - Percentage Breakdown of Value Sales for
Prescription Drugs and OTC Drugs for the Years 2012, 2020 &
2027

REST OF WORLD
Table 136: Rest of World Current & Future Analysis for Vitamin
D Therapy by Route Of Administration - Oral and Parenteral -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 137: Rest of World Historic Review for Vitamin D Therapy
by Route Of Administration - Oral and Parenteral Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 138: Rest of World 15-Year Perspective for Vitamin D
Therapy by Route Of Administration - Percentage Breakdown of
Value Sales for Oral and Parenteral for the Years 2012, 2020 &
2027

Table 139: Rest of World Current & Future Analysis for Vitamin
D Therapy by Application - Other Applications, Osteoporosis,

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033260/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001